Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 211 Results October 1, 2019 Minerva Neurosciences Announces Update for Three Clinical Trials September 26, 2019 Minerva Neurosciences to Host Conference Call and Live Webcast on Tuesday, October 1 at 8:30 AM ET September 24, 2019 Catalent and Minerva Neurosciences Enter Commercial Supply Agreement for Schizophrenia Drug Roluperidone August 5, 2019 Minerva Neurosciences Reports Second Quarter 2019 Financial Results and Business Updates July 29, 2019 Minerva Neurosciences to Report Second Quarter 2019 Financial Results and Business Updates on August 5, 2019 June 24, 2019 Minerva Neurosciences Announces Achievement of Primary and Key Secondary Objectives in Phase 2b Clinical Trial of Seltorexant (MIN-202) in Insomnia June 23, 2019 Minerva Neurosciences to Host Live Conference Call and Webcast With Key Opinion Leaders to Discuss Successful Insomnia Trial With Seltorexant June 12, 2019 Minerva Neurosciences to Present at JMP Securities Life Sciences Conference May 29, 2019 Minerva Neurosciences to Present at Jefferies 2019 Global Healthcare Conference on June 4, 2019 May 13, 2019 Minerva Neurosciences Announces Positive Top Line Results in Phase 2b Clinical Trial With Seltorexant (MIN-202) in Treatment of Depressed Patients With an Inadequate Response to SSRIs and SNRIs «...7891011...20...»